Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.For licensed clinicians. Educational demonstration on synthetic data. Never enter real patient identifiers or protected health information: everything runs in your browser and nothing is sent or stored. Clinical decision support only; not FDA cleared; physician review is required.
CPE-006 · Scope and validity
HG-EXO-01: Exogenous androgen or testosterone therapy
Exogenous androgen or testosterone therapy. Evaluates testosterone therapy OR anabolic-androgenic steroid use documented.
Condition
- testosterone therapy OR anabolic-androgenic steroid use documented
What it reports
- Measured testosterone and gonadotropins reflect the exogenous exposure; baseline status cannot be classified
Diagnostic boundary
- Hypogonadism is not classified while exogenous androgens are being taken.
Evidence
- EV-ES-TRT-2018Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744.Supports: Diagnose with symptoms plus unequivocally low testosterone on two morning fasting samples Contraindications and cautions to therapy; monitoring of hematocrit and PSA Evaluation of the type of hypogonadism with LH and FSH
Cases where this rule fires
Open a case to see this rule fire with real inputs, then change the values until it stops.
Try Biod in your practice
The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.